CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Pilot Process for Receiving Patient Group Input Submissions for Therapeutic Reviews

August 20, 2013
The Canadian Agency for Drugs and Technologies in Health (CADTH) has implemented a pilot process for receiving patient input submissions for therapeutic reviews from patient groups. Patient groups are invited to provide experiences and perspectives about living with the condition for which the drugs included in the therapeutic review are indicat...